Avatar
CBS News News source @cbsnews.com New York 馃嚭馃嚫 1d

#GeneTherapy #CRISPR #PediatricResearch

Link Preview
www.cbsnews.com
After a baby became the world's first CRISPR gene editing therapy patient, CHOP wants to expand treatment to others
One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia.
Avatar
CBS News News source @cbsnews.com New York 馃嚭馃嚫 2w

#SickleCellDisease #GeneTherapy #BlackHistoryMonth

Link Preview
www.cbsnews.com
New Jersey man pain-free thanks to revolutionary sickle cell treatment at Children's Hospital of Philadelphia
A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful for one local family.
Avatar
Yahoo News source @yahoo.com Sunnyvale, California 馃嚭馃嚫 4w

#ReversingAging #GeneTherapy #LongevityTech

Link Preview
www.yahoo.com
Scientists Testing Controversial Human Rejuvenation Compound Called ER-100
Life Biosciences' approach to reversing aging involves injecting a single dose of viruses with gene-reprogramming instructions into participants' eyes, inspired by Nobel laureate Shinya Yamanaka's research on cellular reprogramming.
Avatar
Forbes News source @forbes.com Jersey City, New Jersey 馃嚡馃嚜 Jan 24

#HuntingtonsDisease #GeneTherapy #GeneticResearch

Link Preview
www.forbes.com
Brighter Prospects For Huntington's Disease
For generations, a diagnosis of Huntington's disease has carried a heavy sense of inevitability, with families told that nothing could change the course of the illness once it began.
Avatar
Forbes News source @forbes.com Jersey City, New Jersey 馃嚡馃嚜 Jan 24

#HuntingtonsDisease #GeneTherapy #GeneticResearch

Link Preview
www.forbes.com
Brighter Prospects For Huntington's Disease
For generations, a diagnosis of Huntington's disease has carried a heavy sense of inevitability, with families told that nothing could change the course of the illness once it began.
Avatar
NPR News source @npr.org Washington (state) 馃嚭馃嚫 Jan 20

#SickleCellDisease #GeneTherapy #Medicaid

Link Preview
www.npr.org
Medicaid has a new way to pay for costly sickle cell treatment: Only if it works
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.
Avatar
NPR News source @npr.org Washington (state) 馃嚭馃嚫 Jan 20

#SickleCellDisease #GeneTherapy #Medicaid

Link Preview
www.npr.org
Medicaid has a new way to pay for costly sickle cell treatment: Only if it works
Serenity Cole enjoyed Christmas last month relaxing with her family near her St.
Avatar
NPR News source @npr.org Washington (state) 馃嚭馃嚫 Jan 20

#SickleCellDisease #GeneTherapy #Medicaid

Avatar
ScienceDaily News source @sciencedaily.com Jan 5

#CRISPR #GeneTherapy #Epigenetics

Link Preview
www.sciencedaily.com
This CRISPR breakthrough turns genes on without cutting DNA
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off.
Avatar
ScienceDaily News source @sciencedaily.com Jan 5

#CRISPR #GeneTherapy #Epigenetics

Link Preview
www.sciencedaily.com
This CRISPR breakthrough turns genes on without cutting DNA
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off.
Avatar
Medscape News source @medscape.com New York 馃嚭馃嚫 Jan 5

#Healthcare #GeneTherapy #HealthPolicy

Link Preview
www.medscape.com
Can a Single-Payer Approach Work for Cell, Gene Therapies?
New cell and gene therapies (CGTs) are offering great promise and tremendous challenges for the US healthcare system but with shocking initial costs.
Avatar
Medscape News source @medscape.com New York 馃嚭馃嚫 Jan 5

#Healthcare #GeneTherapy #HealthPolicy

Link Preview
www.medscape.com
Can a Single-Payer Approach Work for Cell, Gene Therapies?
New cell and gene therapies (CGTs) are offering great promise and tremendous challenges for the US healthcare system but with shocking initial costs.